USANA Health (USJ) Stock Statistics & Valuation Metrics
Total Valuation
USANA Health has a market cap or net worth of EUR 236.74M. The enterprise value is EUR 273.74M.
- Market Cap
- EUR 236.74M
- Enterprise Value
- EUR 273.74M
Share Statistics
USANA Health has 18,476,534 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 18,476,534
- Owned by Insiders
- 0.71%
- Owned by Institutions
- 31.90%
Financial Efficiency
USANA Health’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.24%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 2.24%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 589.34K
- Profits Per Employee
- 6,853.503
- Employee Count
- 1,570
- Asset Turnover
- 1.25
- Inventory Turnover
- 1.96
Valuation Ratios
The current PE Ratio of USANA Health is -11.86. USANA Health’s PEG ratio is 0.07.
- PE Ratio
- -11.86
- PS Ratio
- 0.29
- PB Ratio
- 0.50
- Price to FCF
- 16.59
- Price to Operating Cash Flow
- 9.54
- PEG Ratio
- 0.07
Income Statement
In the last 12 months, USANA Health had revenue of 925.26M and earned 10.76M in profits. Earnings per share was 0.58.
- Revenue
- 925.26M
- Gross Profit
- 724.40M
- Operating Income
- 50.86M
- Pretax Income
- 41.53M
- Net Income
- 10.76M
- EBITDA
- 82.07M
- Earnings Per Share (EPS)
- 0.58
Cash Flow
In the last 12 months, operating cash flow was 27.73M and capital expenditures -11.79M, giving a free cash flow of 15.93M billion.
- Operating Cash Flow
- 27.73M
- Free Cash Flow
- 15.93M
- Free Cash Flow per Share
- 0.86
Dividends & Yields
USANA Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.03%
- Earnings Yield
- -8.38%
Stock Price Statistics
- Beta
- 0.69
- 52-Week Price Change
- -25.45%
- 50-Day Moving Average
- 12.39
- 200-Day Moving Average
- 15.15
- Relative Strength Index (RSI)
- 45.38
- Average Volume (3m)
- ―
Important Dates
USANA Health upcoming earnings date is Nov 03, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Aug 04, 2026
- Next Earnings Date
- Nov 03, 2026
- Ex-Dividend Date
- ―
Financial Position
USANA Health as a current ratio of 2.24, with Debt / Equity ratio of 2.63%
- Current Ratio
- 2.24
- Quick Ratio
- 1.45
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- -1.76
- Interest Coverage Ratio
- 60.41
Taxes
In the past 12 months, USANA Health has paid 30.05M in taxes.
- Income Tax
- 30.05M
- Effective Tax Rate
- 0.72
Enterprise Valuation
USANA Health EV to EBITDA ratio is 2.29, with an EV/FCF ratio of 6.01.
- EV to Sales
- 0.10
- EV to EBITDA
- 2.29
- EV to Free Cash Flow
- 6.01
- EV to Operating Cash Flow
- 3.46
Balance Sheet
USANA Health has EUR 168.56M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 168.56M billion.
- Cash & Marketable Securities
- EUR 168.56M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 168.56M
- Net Cash Per Share
- EUR 9.12
- Tangible Book Value Per Share
- EUR 18.24
Margins
Gross margin is 77.45%, with operating margin of 1.35%, and net profit margin of -2.43%.
- Gross Margin
- 77.45%
- Operating Margin
- 1.35%
- Pretax Margin
- 0.28%
- Net Profit Margin
- -2.43%
- EBITDA Margin
- 4.57%
- EBIT Margin
- 0.32%
Analyst Forecast
The average price target for USANA Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -5.39%
- EPS Growth Forecast
- -162.53%
Scores
- Smart Score
- 2
- AI Score
- ―
